Camelid TB Serology Quarterly Report: 1st April to 30th June 2015
Source: environment.data.gov.uk (2024-10-03)

Camelid TB Serology Quarterly Report. Camelid TB Serology Quarterly Report.

Camelid TB Serology
Quarterly Report
Number: 1
Report Period 1st April to 30th June 2015
Issued 07 September 2015

Submission Reason
Explanation
APHA /DEFRA
At Government expense
Parallet Test:
PAR-TB
TB breakdown herd with confirmed M. bovis infection (including Wales where Officially
TB Free Withdrawn [OTFW] status is determined on epidemiological grounds)
PAR-SUS
TB strongly suspected but not currently confirmed by laboratory culture – herd under
restrictions
PAR-TRC
Forward  tracing(s) from an M. bovis-infected camelid herd (includes camelid herds in
Wales only co-located on the same premises with infected cattle, sheep, deer, goats
& pigs)
Serial Test:
SER-CONT
Herd not under restriction but contiguous to a TB-infected herd
SER-COL
Herd not under restriction but co-located with an infected herd of cattle, deer, goats
etc. (Eng & Scot only)
SER-EPI
Herd not under restriction but TB tested due to an epidemiological link with a known
infected herd (e.g. back-tracing)
Commercial/Private
At Owner expense
SER-MVT
Pre- or post-movement test
SER-EXP 
Pre-export test
SER-DIAG
Diagnostic to exclude TB from a differential diagnoses in a herd not restricted (TB
strongly suspected)
SER-RHT
Monitoring - voluntary routine testing (herd nor restricted)
Quarterly Camelid Serology Report
Test Criteria

Quarterly Camelid Serology Report
07 Sep 2015
Table 1a
Country
No.
Samples
Tested
England
210
Wales
108
Non GB
28
Total for Q2
346
Number of Samples tested and Submission Reason  2015 Q2 (April - June)
Table 1b
Submission
Reason
No.
Samples
Tested
Parallel
PAR-TB
89
PAR-TRC
10
Parallel
Sum:
99
Serial
SER-COL
33
SER-CONT
150
SER-EPI
32
Serial
Sum:
215
Commercial/Private Testing SER-MVT
28
SER-RHT
4
Commercial/Private Testing
Sum:
32
Total for Q2
Sum:
346

Quarterly Camelid Serology Report
07 Sep 2015
Table 2a
Country
No.
Samples
Tested
England
432
Wales
163
Non GB
57
Total for Q2
652
Number of Samples tested and Submission Reason 2015 up to end of Q2 (January - June)
Table 2b
APHA/DEFRA
Submission
Reason
No.
Samples
Tested
Parallel
PAR-SUS
12
PAR-TB
113
PAR-TRC
12
Parallel
Sum:
137
Serial
SER-COL
38
SER-CONT
243
SER-EPI
169
Serial
Sum:
450
Commercial/Private Testing
SER-DIAG
2
SER-MVT
59
SER-RHT
4
Commercial/Private Testing
Sum:
65
Total for 2015 up to end
of Q2
652

Quarterly Camelid Serology Report
07 Sep 2015
Table 3a
Submissions Received and Test Positivity in 2015 Q2
Country
Submission
Reason
No.
Submissions
No. Samples
Tested
No.
Positive
Samples
% Positive
Samples
England
Parallel
PAR-TB
3
84
36
42.9%
PAR-TRC
2
10
1
10.0%
Parallel
5
94
37
39.4%
Serial
SER-COL
6
33
1
3.0%
SER-CONT
12
47
5
10.6%
SER-EPI
3
32
0
0
Serial
21
112
6
5.4%
Commercial/Private Testing
SER-RHT
2
4
0
0
Commercial/Private Testing
2
4
0
0
England Total
28
210
43
20.5%
Wales
Parallel
PAR-TB
1
5
3
60.0%
Parallel
1
5
3
60.0%
Serial
SER-CONT
7
103
14
13.6%
Serial
7
103
14
13.6%
Wales Total
8
108
17
15.7%
Non GB
Commercial/Private Testing
SER-MVT
3
28
0
0
Commercial/Private Testing
3
28
0
0
Non GB Total
3
28
0
0
Totals for Q2
39
346
60
17.3 %
Test Positivity in 2015 Q2 (April - June)

Quarterly Camelid Serology Report
07 Sep 2015
Table 3b
Submissions Received and Test Positivity in 2015 up to the end of Q2
Country
Submission
Reason
No.
Submissions
No. Samples
Tested
No.
Positive
Samples
% Positive
Samples
England
Parallel
PAR-SUS
1
10
1
10.0%
PAR-TB
4
108
40
37.0%
PAR-TRC
3
12
2
16.7%
Parallel
8
130
43
33.1%
Serial
SER-COL
8
38
1
2.6%
SER-CONT
18
87
6
6.9%
SER-EPI
7
169
26
15.4%
Serial
33
294
33
11.2%
Commercial/Private Testing
SER-DIAG
2
2
0
0
SER-MVT
2
2
1
50.0%
SER-RHT
2
4
0
0
Commercial/Private Testing
6
8
1
12.5%
England Total
47
432
77
17.8%
Wales
Parallel
PAR-SUS
1
2
2
100.0%
PAR-TB
1
5
3
60.0%
Parallel
2
7
5
71.4%
Serial
SER-CONT
10
156
15
9.6%
Serial
10
156
15
9.6%
Wales Total
12
163
20
12.3%
Non GB
Commercial/Private Testing
SER-MVT
7
57
6
10.5%
Commercial/Private Testing
7
57
6
10.5%
Non GB Total
7
57
6
10.5%
Totals up to
end Q2
66
652
103
15.8 %
Test Positivity in 2015 up to end of Q2 (January - June)

Quarterly Camelid Serology Report
07 Sep 2015
Submissions Received in 2015 up to end of Q2
Analysis
Analysis Description
Q1
No.
samples
tested
Q2
No.
samples
tested
Totals up to end Q2
TC0677
Lateral flow for
Mycobacterium bovis
306
346
652
TC0867
Camelid TB Antibody
ELISA
306
346
652
Table 4: Number of samples Tested by Test Code